참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Carnitine Chloride | HCID 5970 | — |
| 반응물 | Dabco | HCID 9237 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | Norcarnitine | HCID 3081992 | — |
반응 단계
L-carnitine chloride (1.5. g; 0.008 moles) and 1,4 diazabicyclo[2,2,2]octane (5.25 g; 0.05 moles) were dissolved in 50 cc of DMF at 80° C. The resulting solution was subsequently heated up to 125° C. for 2 hours. Upon reaction termination, the solution was cooled in an ice bath a 5° C. After about 2 hours the precipitate which formed consisting of the excess diazabicyclo octane and its N-methyl derivative was filtered off. DMF was distilled under vacuum and the residue dissolved in water and eluted on AMBERLITE IRA 402 resin activated in the OH-l form. The eluate having alkaline pH was shown to consist of diazabicyclo octane and its N-methyl derivative; L-norcarnitine which formed was retained on the resin and was eluted therefrom with 2N HCl.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04599447 |
|---|
| 출처 데이터셋 | uspto-grants-1986_07 |
|---|
| ORD ID | ord-4b7a83338cdf4bc8aacd50edcdfc5d19 |
|---|
| 출처 메모 | uspto-grants-1986_07 |
|---|